Table 1 Patient characteristics.

From: Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis

 

Active GCA

Inactive GCA

Active TA

Inactive TA

n = 6

n = 5

n = 10

n = 10

Age, med (min; max)

77.4 (58.2; 84)

70.1 (64; 80)

43.8 (23.6; 61)

41.4 (23.1; 70.6)

Gender, female, n (%)

3 (50)

3 (60)

8 (80)

9 (90)

Time from diagnosis, med (min; max)

2 (0; 5.5)

2.6 (1.5; 4.5)

2.8 (0.1; 11.6)

4.2 (0.2; 19.8)

Treatment

Immunosuppressant, n (%)

1 (16.7)

0 (0)

4 (40)

4 (40)

TNF inhibitors, n (%)

0 (0)

0 (0)

2 (20)

2 (20)

IL-6 inhibitors, n (%)

0 (0)

0 (0)

0 (0)

1 (10)

Corticosteroids, n (%)

3 (50)

4 (80)

5 (50)

7 (70)

Dose of corticosteroids, med (min; max)

15 (5; 25)

11 (5; 50)

8 (5; 10)

10 (5; 30)

Pulses of corticosteroids

0 (0)

0 (0)

2 (20)

0 (0)

Antibiotics

0 (0)

1 (20)

0 (0)

0 (0)

Symptoms

Ocular symptoms

3 (50)

0 (0)

1 (10)

1 (10)

Articular involvement

1 (16.7)

0 (0)

0 (0)

1 (10)

Cranial symptoms

3 (50)

1 (20)

0 (0)

1 (10)

Carotidynia

0 (0)

0 (0)

3 (30)

1 (10)

Claudication of arm

0 (0)

0 (0)

4 (40)

3 (30)

Claudication of leg

0 (0)

0 (0)

3 (30)

2 (20)

Dyspnoea

0 (0)

0 (0)

1 (10)

0 (0)

C-reactive protein (mg/l), mean (+ /− SD)

11.1 (12.8)

5.3 (6.1)

21.6 (23.6)

3 (5.1)